VCEL

#2057
Vericel Corporation
35.1400 USD
+2.03%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
35.1400
35.1400
Intervallo Annuale
28.9500
43.0000
Variazione giornaliera
+2.03%
Variazione Mensile
+7.17%
Variazione di 6 mesi
-3.33%
Variazione Annuale
-3.33%
Chiusura Precedente
34.4400
Apertura
35.1400
Bid
Ask
Minimo
35.1400
High
35.1400
Volume
65
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 1.7838 B
  • Employee 398
  • Founded 1989
  • CEO Nick Colangelo
  • Website www.vcel.com
  • Headquarter Michigan, United States
  • FIGI BBG000BDCM24
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
112.53
Rapporto prezzo/fatturato
6.8

Vericel Corporation

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan. In the spring of 2014, Aastrom Bio acquired Sanofi's cell therapy and regenerative medicine business which Sanofi had acquired when purchasing Genzyme in 2011. This transformed Aastrom in several ways: it increased the employee count by 8-fold and provided a revenue stream and products to market, which it had not had before. In October 2014, the company changed its name from Aastrom Bio to Vericel and relocated its headquarters from Ann Arbor, Michigan to Cambridge, Massachusetts.

Notizie